
|Articles|June 1, 2002
Botulinum toxin type A approval extends to glabellar lines
Vancouver, British Columbia-The FDA recently approved the injection of botulinum toxin type A (Botox Cosmetic, Allergan, Irvine, CA) to treat moderate to severe glabellar lines in adults under age 65.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Aviceda Therapeutics reports positive phase 2b SIGLEC results for AVD-104 in geographic atrophy
2
Argenx discontinues phase 3 UplighTED trials of efgartigimod SC in thyroid eye disease
3
Strategic approaches optimize teaching and learning in the clinic
4
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
5












































.png)


